• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于其细胞壁定位,DprE1是一个易受攻击的结核病药物靶点。

DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization.

作者信息

Brecik Miroslav, Centárová Ivana, Mukherjee Raju, Kolly Gaëlle S, Huszár Stanislav, Bobovská Adela, Kilacsková Emöke, Mokošová Veronika, Svetlíková Zuzana, Šarkan Michal, Neres João, Korduláková Jana, Cole Stewart T, Mikušová Katarína

机构信息

†Department of Biochemistry, Faculty of Natural Sciences, Comenius University in Bratislava, 842 15 Bratislava, Slovakia.

‡Global Health Institute, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.

出版信息

ACS Chem Biol. 2015 Jul 17;10(7):1631-6. doi: 10.1021/acschembio.5b00237. Epub 2015 Apr 29.

DOI:10.1021/acschembio.5b00237
PMID:25906160
Abstract

The flavo-enzyme DprE1 catalyzes a key epimerization step in the decaprenyl-phosphoryl d-arabinose (DPA) pathway, which is essential for mycobacterial cell wall biogenesis and targeted by several new tuberculosis drug candidates. Here, using differential radiolabeling with DPA precursors and high-resolution fluorescence microscopy, we disclose the unexpected extracytoplasmic localization of DprE1 and periplasmic synthesis of DPA. Collectively, this explains the vulnerability of DprE1 and the remarkable potency of the best inhibitors.

摘要

黄素酶DprE1催化癸异戊二烯基磷酸-d-阿拉伯糖(DPA)途径中的关键差向异构化步骤,该途径对分枝杆菌细胞壁生物合成至关重要,并且是几种新型结核病候选药物的作用靶点。在此,我们通过用DPA前体进行差异放射性标记和高分辨率荧光显微镜观察,揭示了DprE1意外的胞外定位以及DPA的周质合成。总体而言,这解释了DprE1的易损性以及最佳抑制剂的显著效力。

相似文献

1
DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization.由于其细胞壁定位,DprE1是一个易受攻击的结核病药物靶点。
ACS Chem Biol. 2015 Jul 17;10(7):1631-6. doi: 10.1021/acschembio.5b00237. Epub 2015 Apr 29.
2
DprE1--from the discovery to the promising tuberculosis drug target.DprE1——从发现到颇具前景的结核病药物靶点
Curr Pharm Des. 2014;20(27):4379-403. doi: 10.2174/138161282027140630122724.
3
The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis.结核分枝杆菌中最脆弱的靶标之一 DprE1 酶。
Appl Microbiol Biotechnol. 2013 Oct;97(20):8841-8. doi: 10.1007/s00253-013-5218-x. Epub 2013 Sep 14.
4
2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1.2-羧基喹喔啉通过非共价抑制DprE1杀死结核分枝杆菌。
ACS Chem Biol. 2015 Mar 20;10(3):705-14. doi: 10.1021/cb5007163. Epub 2014 Dec 9.
5
Structural studies of Mycobacterium tuberculosis DprE1 interacting with its inhibitors.结核分枝杆菌DprE1与其抑制剂相互作用的结构研究。
Drug Discov Today. 2017 Mar;22(3):526-533. doi: 10.1016/j.drudis.2016.09.014. Epub 2016 Sep 22.
6
Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.通过分子建模、模拟和静电研究对结核分枝杆菌(Mtb)DprE1和DprE2的结构、动力学及相互作用进行研究。
PLoS One. 2015 Mar 19;10(3):e0119771. doi: 10.1371/journal.pone.0119771. eCollection 2015.
7
Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads.作为抗结核药物先导的必需分枝杆菌细胞壁脂肪酶(Rv3802c)抑制剂。
Chem Commun (Camb). 2011 May 14;47(18):5166-8. doi: 10.1039/c0cc05635a. Epub 2011 Mar 7.
8
Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase.作为抗分枝杆菌剂的苯并噻唑的发现:合成、构效关系以及与结核分枝杆菌癸异戊烯基磷酸化-β-D-核糖2'-氧化酶的结合研究
Bioorg Med Chem. 2015 Dec 15;23(24):7694-710. doi: 10.1016/j.bmc.2015.11.017. Epub 2015 Nov 18.
9
Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis.DprE1 抑制剂的发展概述:对抗结核病的威胁。
J Med Chem. 2018 Oct 11;61(19):8563-8593. doi: 10.1021/acs.jmedchem.8b00281. Epub 2018 Jun 12.
10
Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.结核分枝杆菌中DprE1介导的苯并噻嗪酮耐药性的特征分析
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6451-6459. doi: 10.1128/AAC.01523-16. Print 2016 Nov.

引用本文的文献

1
5-(3,5-Dinitrophenyl)-1,3,4-oxadiazol-2-amine derivatives, their precursors, and analogues: Synthesis and evaluation of novel highly potent antitubercular agent.5-(3,5-二硝基苯基)-1,3,4-恶二唑-2-胺衍生物、其前体及类似物:新型高效抗结核药物的合成与评价
PLoS One. 2025 May 29;20(5):e0324608. doi: 10.1371/journal.pone.0324608. eCollection 2025.
2
Real-time evaluation of macozinone activity against through bacterial nanomotion analysis.通过细菌纳米运动分析对马佐醌活性进行实时评估。 (你提供的原文“against through”中间似乎少了些内容,这可能会影响对完整意思的理解,但按照现有内容就是这样翻译。)
Antimicrob Agents Chemother. 2025 Jan 31;69(1):e0131824. doi: 10.1128/aac.01318-24. Epub 2024 Nov 27.
3
A Review of Antibacterial Candidates with New Modes of Action.
具有新型作用机制的抗菌候选药物综述。
ACS Infect Dis. 2024 Oct 11;10(10):3440-3474. doi: 10.1021/acsinfecdis.4c00218. Epub 2024 Jul 17.
4
Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial -Alkyl Nitrobenzamides.新型抗分枝杆菌α-烷基硝基苯甲酰胺的合成、活性、毒性及计算机模拟研究
Pharmaceuticals (Basel). 2024 May 9;17(5):608. doi: 10.3390/ph17050608.
5
Identification of DprE1 inhibitors for tuberculosis through integrated in-silico approaches.通过整合的计算方法鉴定结核分枝杆菌 DprE1 抑制剂。
Sci Rep. 2024 May 17;14(1):11315. doi: 10.1038/s41598-024-61901-x.
6
Three-component systems represent a common pathway for extracytoplasmic addition of pentofuranose sugars into bacterial glycans.三组分系统代表了一种将戊呋喃糖额外添加到细菌聚糖中的常见胞外途径。
Proc Natl Acad Sci U S A. 2024 May 21;121(21):e2402554121. doi: 10.1073/pnas.2402554121. Epub 2024 May 15.
7
Mycobacterial Targets for Thiourea Derivatives: Opportunities for Virtual Screening in Tuberculosis Drug Discovery.硫脲衍生物的分枝杆菌靶标:结核病药物发现中的虚拟筛选机会。
Curr Med Chem. 2024;31(29):4703-4724. doi: 10.2174/0109298673276076231124104513.
8
Both Nitro Groups Are Essential for High Antitubercular Activity of 3,5-Dinitrobenzylsulfanyl Tetrazoles and 1,3,4-Oxadiazoles through the Deazaflavin-Dependent Nitroreductase Activation Pathway.两个硝基均为 3,5-二硝基苄硫基四唑和 1,3,4-恶二唑通过去氮黄素依赖型硝基还原酶激活途径发挥高抗结核活性的必需基团。
J Med Chem. 2024 Jan 11;67(1):81-109. doi: 10.1021/acs.jmedchem.3c00925. Epub 2023 Dec 29.
9
Effects of benzothiazinone and ethambutol on the integrity of the corynebacterial cell envelope.苯并噻嗪酮和乙胺丁醇对棒状细菌细胞壁完整性的影响。
Cell Surf. 2023 Nov 10;10:100116. doi: 10.1016/j.tcsw.2023.100116. eCollection 2023 Dec 15.
10
Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis.基于苯并吗啉的新型DprE1可逆抑制剂的发现,用于治疗结核病。
Microbiol Spectr. 2023 Sep 12;11(5):e0472122. doi: 10.1128/spectrum.04721-22.